New relocation travel process improves global mobility for pharma company
Operating efficiency improvement on track
Valuation to improve on ODM business spin-off
CoR sequentially improved turning to positive 2Q net profit growth; first interim dividend in place
Proving That Manager Actions Improve Engagement
Improved earnings visibility favours re-rating
Improving Trust and Security in Open Source Projects
Earnings outlook to mildly improve
Improving cost efficiency with rapid sales growt
China Economy–Exports improved thanks to base effect and price factor